{"id":40039,"date":"2020-09-23T00:23:00","date_gmt":"2020-09-23T00:23:00","guid":{"rendered":"https:\/\/idafoundation.org\/?p=40039"},"modified":"2026-02-24T00:26:43","modified_gmt":"2026-02-24T00:26:43","slug":"invitation-to-bid-itb-on-behalf-of-stop-tb-gdf-4","status":"publish","type":"post","link":"https:\/\/idafoundation.org\/fr\/invitation-to-bid-itb-on-behalf-of-stop-tb-gdf-4\/","title":{"rendered":"Invitation to Bid (ITB) on behalf of Stop TB\/GDF"},"content":{"rendered":"<p><strong>22 September 2020<\/strong>&nbsp;&#8211; Geneva, Switzerland &#8211; On behalf of Stop TB Partnership\u2019s Global Drug Facility (GDF), IDA Foundation (IDA), the GDF- contracted procurement agent, invites all eligible suppliers to submit bids (ITB) for:<\/p>\n\n\n\n<p><strong>ITB-IDA\/GDF-FLD\/20<\/strong><strong>20<\/strong><strong>\/001<\/strong>, for medicines for the treatment of drug-sensitive forms of tuberculosis, and<\/p>\n\n\n\n<p><strong>ITB-IDA\/GDF-SLD\/20<\/strong><strong>20<\/strong><strong>\/002<\/strong>, for medicines and related products for the treatment of drug-resistant forms of tuberculosis.<\/p>\n\n\n\n<p>The purpose of the ITBs is to select a panel of suppliers who will enter into a long-term agreement with IDA.<\/p>\n\n\n\n<p>The ITBs are open to bidders whose products have been deemed eligible for inclusion in the tender in compliance with&nbsp;<a href=\"http:\/\/www.stoptb.org\/gdf\/drugsupply\/quality_sourcing_process.asp\" target=\"_blank\" rel=\"noreferrer noopener\">GDF&#8217;s Quality Assurance policy and procedures<\/a>. A bid submitted for a product\/s for which the bidder has not received regulatory approval status in accordance with the GDF Quality Assurance policy and procedures shall not be considered for the ITB evaluation.<\/p>\n\n\n\n<p>All bids are subject to the Instructions to Bidders and other provisions, specifications and instructions as contained in this dossier.<\/p>\n\n\n\n<p><strong>UPDATE 30 September 2020<\/strong>&nbsp;&#8211; Some of our bidders requested clarification on this year&#8217;s ITB.<\/p>\n\n\n\n<p>For ITB-IDA\/GDF-FLD\/2020\/001 find the response\u00a0<a href=\"https:\/\/idafoundation.org\/fr\/media\/wysiwyg\/GDF_ITB\/ITB2020\/QA_IDAGDF_FLD2020-001_final.pdf\/\" target=\"_blank\" rel=\"noreferrer noopener\">her<\/a><a href=\"https:\/\/idafoundation.org\/wp-content\/uploads\/2026\/02\/QA_IDAGDF_FLD2020-001_final.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">e<\/a>. And for ITB-IDA\/GDF-SLD\/2020\/002 find the response\u00a0<a href=\"https:\/\/idafoundation.org\/wp-content\/uploads\/2026\/02\/QA_IDAGDF_SLD-2020-002_final.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">ici<\/a>.<\/p>\n\n\n\n<p>The ITB comprises of the following:<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">For ITB-IDA\/GDF-FLD\/2020\/001:<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/idafoundation.org\/fr\/media\/wysiwyg\/GDF_ITB\/ITB2020\/2020_ITB_document_FLD_final.pdf\/\" target=\"_blank\" rel=\"noreferrer noopener\">ITB document FLD 2020<\/a>\u00a0<\/li>\n\n\n\n<li><a href=\"https:\/\/idafoundation.org\/fr\/media\/wysiwyg\/GDF_ITB\/ITB2020\/Annex_A1_-_Technical_FLD_Bid_Response_Form.xlsx\/\" target=\"_blank\" rel=\"noreferrer noopener\">Annex A1: Technical TB Bid Response Form (Excel spreadsheet)<\/a><\/li>\n<\/ul>\n\n\n\n<ol start=\"1\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/idafoundation.org\/fr\/media\/wysiwyg\/GDF_ITB\/ITB2020\/Annex_A2_-_Financial_FLD_Bid_Response_Form.xlsx\/\" target=\"_blank\" rel=\"noreferrer noopener\">Annex A2: Financial TB Bid Response Form (Excel spreadsheet)<\/a><\/li>\n<\/ol>\n\n\n\n<ol start=\"1\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/idafoundation.org\/fr\/media\/wysiwyg\/GDF_ITB\/ITB2020\/Annex_B_-_List_and_technical_specifications_of_products_FLD.pdf\/\" target=\"_blank\" rel=\"noreferrer noopener\">Annex B: List and technical specifications of products<\/a><\/li>\n<\/ol>\n\n\n\n<ol start=\"1\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/idafoundation.org\/fr\/media\/wysiwyg\/GDF_ITB\/ITB2020\/Annex_C_-_Response_Form_for_TB_medicines_registration.xlsx\/\" target=\"_blank\" rel=\"noreferrer noopener\">Annex C: Response Form for TB medicines registration<\/a><\/li>\n<\/ol>\n\n\n\n<ol start=\"1\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/idafoundation.org\/fr\/media\/wysiwyg\/GDF_ITB\/ITB2020\/Annex_D_-_IDA_model_long-term_agreement.pdf\/\" target=\"_blank\" rel=\"noreferrer noopener\">Annex D: IDA model long-term agreement (LTA)<\/a><\/li>\n<\/ol>\n\n\n\n<ol start=\"1\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/idafoundation.org\/fr\/media\/wysiwyg\/GDF_ITB\/ITB2020\/Annex_E_-_IDA_general_terms_and_conditions.pdf\/\" target=\"_blank\" rel=\"noreferrer noopener\">Annex E: IDA general terms and conditions<\/a><\/li>\n<\/ol>\n\n\n\n<ol start=\"1\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/idafoundation.org\/fr\/media\/wysiwyg\/GDF_ITB\/ITB2020\/Annex_F_-_IDA_code_of_conduct.pdf\/\" target=\"_blank\" rel=\"noreferrer noopener\">Annex F: IDA code of conduct<\/a><\/li>\n<\/ol>\n\n\n\n<ol start=\"1\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/idafoundation.org\/fr\/media\/wysiwyg\/GDF_ITB\/ITB2020\/Annex_G_-_GDF_access_to_supplier_information.pdf\/\" target=\"_blank\" rel=\"noreferrer noopener\">Annex G: GDF access to WHO PQP\/ERP supplier information<\/a><\/li>\n<\/ol>\n\n\n\n<ol start=\"1\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/idafoundation.org\/fr\/media\/wysiwyg\/GDF_ITB\/ITB2020\/Annex_H_-_Indicative_non-binding_estimated_quantities_FLD.pdf\/\" target=\"_blank\" rel=\"noreferrer noopener\">Annex H: Indicative non-binding estimated quantities<\/a><\/li>\n<\/ol>\n\n\n\n<ol start=\"1\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/idafoundation.org\/fr\/media\/wysiwyg\/GDF_ITB\/ITB2020\/Annex_I_-_GMSD_address_list.pdf\/\" target=\"_blank\" rel=\"noreferrer noopener\">Annex I: GMSD address list<\/a><\/li>\n<\/ol>\n\n\n\n<ol start=\"1\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/idafoundation.org\/fr\/media\/wysiwyg\/GDF_ITB\/ITB2020\/Annex_J_-_Global_Drug_Facility_packaging_guidelines.pdf\/\" target=\"_blank\" rel=\"noreferrer noopener\">Annex J: Global Drug Facility packaging guidelines<\/a><\/li>\n<\/ol>\n\n\n\n<ol start=\"1\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/idafoundation.org\/fr\/media\/wysiwyg\/GDF_ITB\/ITB2020\/Annex_K_-_ITB_checklist.docx\/\" target=\"_blank\" rel=\"noreferrer noopener\">Annex K: ITB checklist FLD<\/a><\/li>\n<\/ol>\n\n\n\n<ol start=\"1\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/idafoundation.org\/fr\/media\/wysiwyg\/GDF_ITB\/ITB2020\/Annex_L-_List_of_Priority_Countries_for_Registration.pdf\/\" target=\"_blank\" rel=\"noreferrer noopener\">Annex L: List of priority countries for registration<\/a><\/li>\n<\/ol>\n\n\n\n<ol start=\"1\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/idafoundation.org\/fr\/media\/wysiwyg\/GDF_ITB\/ITB2020\/Annex_X_-_Form_for_Requests_for_Clarifications_or_Complaints.docx\/\" target=\"_blank\" rel=\"noreferrer noopener\">Annex X: Form for Requests for Clarifications or Complaints after ITB awarding<\/a><\/li>\n<\/ol>\n\n\n\n<p><br><br>You can also download all ITB-IDA\/GDF-FLD\/2020\/001 files in one .zip file by clicking&nbsp;<a href=\"https:\/\/idafoundation.org\/fr\/media\/wysiwyg\/GDF_ITB\/ITB2020\/FLD2020.zip\/\" target=\"_blank\" rel=\"noreferrer noopener\">ici<\/a>.<a href=\"https:\/\/www.idafoundation.org\/en\/blog\/post\/itb-2020#_msocom_1\"><\/a><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">For ITB-IDA\/GDF-SLD\/2020\/002:<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/idafoundation.org\/fr\/media\/wysiwyg\/GDF_ITB\/ITB2020SLD\/2020_ITB_document_SLD_final.pdf\/\" target=\"_blank\" rel=\"noreferrer noopener\">ITB document SLD 2020<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/idafoundation.org\/fr\/media\/wysiwyg\/GDF_ITB\/ITB2020SLD\/Annex_A1_-_Technical_SLD_Bid_Response_Form.xlsx\/\" target=\"_blank\" rel=\"noreferrer noopener\">Annex A1: Technical TB Bid Response Form (Excel spreadsheet)<\/a><\/li>\n<\/ul>\n\n\n\n<ol start=\"2\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/idafoundation.org\/fr\/media\/wysiwyg\/GDF_ITB\/ITB2020SLD\/Annex_A2_-_Financial_SLD_Bid_Response_Form.xlsx\/\" target=\"_blank\" rel=\"noreferrer noopener\">Annex A2: Financial TB Bid Response Form (Excel spreadsheet)<\/a><\/li>\n<\/ol>\n\n\n\n<ol start=\"2\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/idafoundation.org\/fr\/media\/wysiwyg\/GDF_ITB\/ITB2020SLD\/Annex_B_-_List_and_technical_specifications_of_products_SLD.pdf\/\" target=\"_blank\" rel=\"noreferrer noopener\">Annex B: List and technical specifications of products<\/a><\/li>\n<\/ol>\n\n\n\n<ol start=\"2\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/idafoundation.org\/fr\/media\/wysiwyg\/GDF_ITB\/ITB2020SLD\/Annex_C_-_Response_Form_for_TB_medicines_registration.xlsx\/\" target=\"_blank\" rel=\"noreferrer noopener\">Annex C: Response Form for TB medicines registration<\/a><\/li>\n<\/ol>\n\n\n\n<ol start=\"2\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/idafoundation.org\/fr\/media\/wysiwyg\/GDF_ITB\/ITB2020SLD\/Annex_D_-_IDA_model_long-term_agreement.pdf\/\" target=\"_blank\" rel=\"noreferrer noopener\">Annex D: IDA model long-term agreement (LTA)<\/a><\/li>\n<\/ol>\n\n\n\n<ol start=\"2\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/idafoundation.org\/fr\/media\/wysiwyg\/GDF_ITB\/ITB2020SLD\/Annex_E_-_IDA_general_terms_and_conditions.pdf\/\" target=\"_blank\" rel=\"noreferrer noopener\">Annex E: IDA general terms and conditions<\/a><\/li>\n<\/ol>\n\n\n\n<ol start=\"2\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/idafoundation.org\/fr\/media\/wysiwyg\/GDF_ITB\/ITB2020SLD\/Annex_F_-_IDA_code_of_conduct.pdf\/\" target=\"_blank\" rel=\"noreferrer noopener\">Annex F: IDA code of conduct<\/a><\/li>\n<\/ol>\n\n\n\n<ol start=\"2\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/idafoundation.org\/fr\/media\/wysiwyg\/GDF_ITB\/ITB2020SLD\/Annex_G_-_GDF_access_to_supplier_information.pdf\/\" target=\"_blank\" rel=\"noreferrer noopener\">Annex G: GDF access to WHO PQP\/ERP supplier information<\/a><\/li>\n<\/ol>\n\n\n\n<ol start=\"2\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/idafoundation.org\/fr\/media\/wysiwyg\/GDF_ITB\/ITB2020SLD\/Annex_H_-_Indicative_non-binding_estimated_quantities_SLD.pdf\/\" target=\"_blank\" rel=\"noreferrer noopener\">Annex H: Indicative non-binding estimated quantities<\/a><\/li>\n<\/ol>\n\n\n\n<ol start=\"2\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/idafoundation.org\/fr\/media\/wysiwyg\/GDF_ITB\/ITB2020SLD\/Annex_I_-_GMSD_address_list.pdf\/\" target=\"_blank\" rel=\"noreferrer noopener\">Annex I: GMSD address list<\/a><\/li>\n<\/ol>\n\n\n\n<ol start=\"2\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/idafoundation.org\/fr\/media\/wysiwyg\/GDF_ITB\/ITB2020SLD\/Annex_J_-_Global_Drug_Facility_packaging_guidelines.pdf\/\" target=\"_blank\" rel=\"noreferrer noopener\">Annex J: Global Drug Facility packaging guidelines<\/a><\/li>\n<\/ol>\n\n\n\n<ol start=\"2\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/idafoundation.org\/fr\/media\/wysiwyg\/GDF_ITB\/ITB2020SLD\/Annex_K_-_ITB_checklist.docx\/\" target=\"_blank\" rel=\"noreferrer noopener\">Annex K: ITB checklist SLD<\/a><\/li>\n<\/ol>\n\n\n\n<ol start=\"2\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/idafoundation.org\/fr\/media\/wysiwyg\/GDF_ITB\/ITB2020SLD\/Annex_L-_List_of_Priority_Countries_for_Registration.pdf\/\" target=\"_blank\" rel=\"noreferrer noopener\">Annex L: List of priority countries for registration<\/a><\/li>\n<\/ol>\n\n\n\n<ol start=\"2\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/idafoundation.org\/fr\/media\/wysiwyg\/GDF_ITB\/ITB2020SLD\/Annex_X_-_Form_for_Requests_for_Clarifications_or_Complaints.docx\/\" target=\"_blank\" rel=\"noreferrer noopener\">Annex X: Form for Requests for Clarifications or Complaints after ITB awarding<\/a><\/li>\n<\/ol>\n\n\n\n<p><br>You can also download all ITB-IDA\/GDF-SLD\/2020\/002 files in one .zip file by clicking&nbsp;<a href=\"https:\/\/idafoundation.org\/fr\/media\/wysiwyg\/GDF_ITB\/ITB2020SLD\/SLD.zip\/\" target=\"_blank\" rel=\"noreferrer noopener\">ici<\/a>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Supplementary information and deadlines<\/h3>\n\n\n\n<p>Bidders are requested to quote unit prices in accordance with the following delivery terms: EXW (Ex-Works), FCA (Free Carrier Alongside) and DAP India.<\/p>\n\n\n\n<p>Failure to adhere to the requirements of the ITB may lead to disqualification of the bidder and\/or rejection of the bid.<\/p>\n\n\n\n<p>Deadlines for electronic submission of Technical and Financial Bids:<\/p>\n\n\n\n<p><strong>Monday 05<\/strong><strong>&nbsp;October&nbsp;<\/strong><strong>2020<\/strong>, 16:00h IST (India Standard Time) for&nbsp;<strong>ITB-IDA\/GDF-FLD\/20<\/strong><strong>20<\/strong><strong>\/001<\/strong><\/p>\n\n\n\n<p>et<\/p>\n\n\n\n<p><strong>Wedn<\/strong><strong>esday&nbsp;<\/strong><strong>07 October 2020<\/strong>, 16:00h IST (India Standard Time) for&nbsp;<strong>ITB-IDA\/GDF-SLD\/20<\/strong><strong>20<\/strong><strong>\/002<\/strong>.<\/p>\n\n\n\n<p>Faxed or proposals sent through courier are not acceptable.<\/p>\n\n\n\n<p>Public opening of the Financial Bids of both ITBs, accessible remotely, will take place on&nbsp;<strong>14 October<\/strong>&nbsp;<strong>2020<\/strong>&nbsp;at following times:<\/p>\n\n\n\n<p>&#8211; at&nbsp;<strong>1<\/strong><strong>3<\/strong><strong>.30<\/strong>&nbsp;IST (India Standard Time) for&nbsp;<strong>ITB-IDA\/GDF-FLD\/20<\/strong><strong>20<\/strong><strong>\/001<\/strong><\/p>\n\n\n\n<p>et<\/p>\n\n\n\n<p>&#8211; at&nbsp;<strong>1<\/strong><strong>4<\/strong><strong>.30<\/strong>&nbsp;IST (India Standard Time) for&nbsp;<strong>ITB-IDA\/GDF-SLD\/20<\/strong><strong>20<\/strong><strong>\/002<\/strong><\/p>","protected":false},"excerpt":{"rendered":"<p>22 September 2020&nbsp;&#8211; Geneva, Switzerland &#8211; On behalf of Stop TB Partnership\u2019s Global Drug Facility (GDF), IDA Foundation (IDA), the GDF- contracted procurement agent, invites all eligible suppliers to submit bids (ITB) for: ITB-IDA\/GDF-FLD\/2020\/001, for medicines for the treatment of drug-sensitive forms of tuberculosis, and ITB-IDA\/GDF-SLD\/2020\/002, for medicines and related products for the treatment of [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":40040,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"off","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[197,182,196],"tags":[],"class_list":["post-40039","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-global-drug-facility","category-news","category-stop-tb-partnership"],"_links":{"self":[{"href":"https:\/\/idafoundation.org\/fr\/wp-json\/wp\/v2\/posts\/40039","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idafoundation.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idafoundation.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idafoundation.org\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/idafoundation.org\/fr\/wp-json\/wp\/v2\/comments?post=40039"}],"version-history":[{"count":1,"href":"https:\/\/idafoundation.org\/fr\/wp-json\/wp\/v2\/posts\/40039\/revisions"}],"predecessor-version":[{"id":40043,"href":"https:\/\/idafoundation.org\/fr\/wp-json\/wp\/v2\/posts\/40039\/revisions\/40043"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idafoundation.org\/fr\/wp-json\/wp\/v2\/media\/40040"}],"wp:attachment":[{"href":"https:\/\/idafoundation.org\/fr\/wp-json\/wp\/v2\/media?parent=40039"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idafoundation.org\/fr\/wp-json\/wp\/v2\/categories?post=40039"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idafoundation.org\/fr\/wp-json\/wp\/v2\/tags?post=40039"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}